Back to Search
Start Over
POSB120 Economic Assessment of Ribociclib for the Treatment of Postmenopausal Patients with Advanced Breast Cancer HR-Positive, HER2-Negative.
- Source :
-
Value in Health . 2022 Supplement, Vol. 25 Issue 1, pS84-S84. 1p. - Publication Year :
- 2022
- Subjects :
- *METASTATIC breast cancer
*CANCER patients
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 25
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 154761701
- Full Text :
- https://doi.org/10.1016/j.jval.2021.11.393